• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Rabbit anti-Human KRAS+HRAS+NRAS Monoclonal Antibody

The antibody against KRAS+HRAS+NRAS was raised in Rabbit using the recombinant fusion protein containing a sequence corresponding to amino acids 1-188 of human NRAS (P01111) as the immunogen. The monoclonal antibody exists as a isotype IgG, by affinity purification. This antibody has been validated on WB, IF/ICC, ELISA.

ADA-16499A

The antibody against KRAS+HRAS+NRAS was raised in Rabbit using the recombinant fusion protein containing a sequence corresponding to amino acids 1-188 of human NRAS (P01111) as the immunogen. The monoclonal antibody exists as a isotype IgG, by affinity purification. This antibody has been validated on WB, IF/ICC, ELISA.

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ADA-16499A ClonalityMonoclonal
Host SpeciesRabbitTarget NameKRAS+HRAS+NRAS
Target SynonymsC-K-RAS; CFC2; K-RAS2A; K-RAS2B; K-RAS4A; K-RAS4B; KI-RAS; KRAS1; KRAS2; NS; NS3; RALD; RASK2; c-Ki-ras2; KRAS+HRAS+NRASFormLiquid
Species ReactivityHuman, Mouse, RatIsotypeIgG
Storage Buffer50% Glycerol, 0.05% BSA, PBS with 0.02% sodium azide, pH7.3.Purification MethodAffinity purification
Positive SamplesC6, NIH/3T3, Rat brain, 293T, HT-29, MCF7, Mouse brain, Mouse lungApplicationELISA, WB, IF/ICC

Immunogen Information


Immunogen DescriptionRecombinant fusion protein containing a sequence corresponding to amino acids 1-188 of human NRAS (P01111).Target SpeciesHuman
Immunogen SequenceMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNSKSFADINLYREQIKRVKDSDDVPMVLVGNKCDLPTRTVDTKQAHELAKSYGIPFIETSAKTRQGVEDAFYTLVREIRQYRMKKLNSSDDGTQGCMGLPCVVUniprot IDP01111, P01112, P01116

Inquire Rabbit anti-Human KRAS+HRAS+NRAS Monoclonal Antibody Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification